Cite

HARVARD Citation

    Turtle, C. et al. (2016). Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape. Expert review of hematology. 9 (8), pp. 719-721. [Online]. 
  
Back to record